Samuel Agresta, Chief Medical Officer at Foghorn Therapeutics Inc. (FHTX), sold 622,594 shares at $8.25 ($5.1M) on 2023-08-16, disclosed to the SEC on 2023-08-18.
Open-market sale of $5.1M FHTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.25 | 311,297 | $2.6M | 50.0% |
| 2 | $8.25 | 311,297 | $2.6M | 50.0% |
| Total | $8.25 avg | 622,594 | $5.1M | 100% |